ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 107 filers reported holding ADMA BIOLOGICS INC in Q1 2021. The put-call ratio across all filers is 2.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,000 | -50.0% | 1,008 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | +100.0% | 1,008 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | -83.3% | 1,008 | -54.2% | 0.00% | – |
| Q1 2020 | $6,000 | 0.0% | 2,202 | +47.6% | 0.00% | – |
| Q4 2019 | $6,000 | -14.3% | 1,492 | -2.0% | 0.00% | – |
| Q3 2019 | $7,000 | +40.0% | 1,522 | +18.1% | 0.00% | – |
| Q2 2019 | $5,000 | +25.0% | 1,289 | +30.7% | 0.00% | – |
| Q1 2019 | $4,000 | +100.0% | 986 | +18.9% | 0.00% | – |
| Q4 2018 | $2,000 | -71.4% | 829 | -23.2% | 0.00% | -100.0% |
| Q3 2018 | $7,000 | -99.6% | 1,080 | +172.7% | 0.00% | – |
| Q2 2018 | $1,787,000 | – | 396 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $15,520,000 | 13.71% |
| Stonepine Capital Management, LLC | 6,940,000 | $26,927,200 | 11.33% |
| Caligan Partners LP | 2,676,093 | $10,383,241 | 8.64% |
| Altium Capital Management LP | 2,870,000 | $11,135,600 | 5.66% |
| AWM Investment Company, Inc. | 6,015,000 | $23,338,200 | 3.36% |
| EAM Investors, LLC | 1,749,598 | $6,788,440 | 1.40% |
| Perceptive Advisors | 11,900,255 | $46,172,989 | 1.30% |
| EAM Global Investors LLC | 836,323 | $3,244,933 | 0.84% |
| Potomac Capital Management, Inc. | 120,000 | $466 | 0.54% |
| OBERWEIS ASSET MANAGEMENT INC/ | 536,900 | $2,083,172 | 0.44% |